This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AC-201

TWi Pharmaceuticals, Inc.

Drug Names(s): AC-201, Diacerein, Diacetylrhein

Description: AC-201 is an orally potent small molecule that modulate the transcriptional cytokine synthesis of IL-1ß (reduces) and IL-1RA (increases). Reduction of IL-1ß has been demonstrated to be effective in treating a variety of inflammatory diseases including Arthritis, Diabetic Nephropathy (DN) and Diabetic Mellitus (DM).


AC-201 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug